COSCIENS Biopharma Inc T.AEZ

Primary Symbol: T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc

Bullboard Posts

Comment by cavinsinon May 01, 2017 11:41am

104 Views

Post# 26187152

RE:RE:RE:Aeterna Zentaris Announces that ZoptEC Phase 3 FAILED

Thats for sure, I was debating wheather to unload this morning, but I didn't,
I will watch if it recovers a bit, next few months, then get out, and if not, then may wait to the end of the year, hopefully some form of interest may return for the SP
Damn.. this is dissapointing.

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments